Study protocol for a randomised, double-blind, placebo-controlled crossover trial assessing the impact of the SGLT2 inhibitor empagliflozin on postprandial hypoglycaemia after gastric bypass

INTRODUCTION: Postprandial hypoglycaemia after gastric bypass surgery (also known as postbariatric hypoglycaemia or PBH) is an increasingly encountered clinical problem. PBH is characterised by meal-induced rapid spikes and consequent falls in glycaemia, resulting in both hypoglycaemia burden and hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Antonio, Emara, Ahmed Fahiem Abdelsalam, Herzig, David, Melmer, Andreas, Vogt, Andreas P, Nakas, Christos T, Facchinetti, Andrea, Dalla Man, Chiara, Bally, Lia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486284/
https://www.ncbi.nlm.nih.gov/pubmed/36123073
http://dx.doi.org/10.1136/bmjopen-2021-060668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486284/
https://www.ncbi.nlm.nih.gov/pubmed/36123073
http://dx.doi.org/10.1136/bmjopen-2021-060668

Ejemplares similares